G
Galectin Therapeutics
GALT
2.23000
USD
-0.27
(-10.80%)
مفتوح الان
حجم التداول
1,272
الربح لكل سهم
0
العائد الربحي
0
P/E
-3
حجم السوق
163,168,688
العنوان: Galectin Therapeutics
القطاع: Healthcare
الصناعة: Biotechnology
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.